4.7 Article

Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity

Journal

COLLOIDS AND SURFACES B-BIOINTERFACES
Volume 108, Issue -, Pages 80-84

Publisher

ELSEVIER
DOI: 10.1016/j.colsurfb.2013.02.033

Keywords

Silver nanoparticles; Origanum vulgare; FT-IR; Human pathogens; Dose-response activity

Funding

  1. University Grant Commission (UGC)
  2. Science & Engineering Research Board (SERB)
  3. Department of Science and Technology - Fund for Improvement of S & T Infrastructure in Universities and Higher Educational Institutions (DST-FIST)
  4. Department of Science and Technology (DST) through INSPIRE Fellowship scheme

Ask authors/readers for more resources

In the present study, we achieved silver nanoparticles using the aqueous extract of Origanum vulgare (Oregano) by reducing 1 mM silver nitrate (AgNO3) solution. The green synthesized silver nanoparticles were characterized by high throughput techniques like UV-vis spectroscopy, Fourier infrared spectroscopy (FT-IR), field emission-scanning electron microscopy (FE-SEM), X-ray diffraction (XRD) and dynamic light scattering measurements. Morphologically, the nanoparticles were found to be spherical with an average particle size distribution of 136 +/- 10.09 nm. FT-IR spectral analysis illustrates the occurrence of possible biomolecules required for the reduction of silver ions. The obtained nanoparticles were stable (-26 +/- 0.77 mV) at ambient temperature. The biosynthesized nanoparticles were found to be impressive in inhibiting human pathogens. The green synthesized silver nanoparticles showed dose dependent response against human lung cancer A549 cell line (LD50 - 100 mu g/ml). (c) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available